Mark C. Genovese

Stanford Medicine

Papers

1

Total Citations

677

H-Index

1

About

Mark C. Genovese is a leading figure in rheumatology and autoimmune disease research, with a career defined by pioneering work in biomarker discovery and targeted therapies. His early contributions include the development of autoantigen microarrays, a groundbreaking tool that enabled multiplex characterization of autoantibody responses—a technique that has since garnered over 677 citations and revolutionized the study of autoimmune serology. This innovation laid the foundation for more precise diagnostics and personalized treatment approaches in conditions like rheumatoid arthritis and lupus. Genovese’s impact extends to clinical trials, where he has been instrumental in evaluating novel biologic agents, including those targeting T-cell co-stimulation and cytokine pathways, significantly advancing therapeutic options for patients. His work has been recognized with numerous honors, including leadership roles in major rheumatology societies and editorial boards. With a citation record reflecting thousands of references across his publications, Genovese’s research continues to shape the understanding and management of autoimmune diseases, bridging the gap between bench science and bedside care.

Research Focus

Key Achievements

1
H-Index
1
Papers
677
Total Citations
677
Avg Citations/Paper
🏆 Most Cited Paper
Autoantigen microarrays for multiplex characterization of autoantibody responses
677 citations · 2002
📈 Most Prolific Year: 2002 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Stanford Medicine

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago